Common Shares of Beneficial Interest of Bitwise Hyperliquid ETFBHYP

If you squint at the ticker BHYP on Nasdaq, you might imagine you’ve found the ETF equivalent of a crypto futures contract-something fast, liquid, and packed with leverage. Instead, you’ve bought a front-row seat to the time-honoured tradition of wrapping a plain index in a flashy name and charging for the privilege. The Nasdaq listing proves the ticker exists and trades; the SEC filings prove the fund is an index tracker dressed in “hyperliquid” clothing, with a stated methodology and a fee that quietly clocks in well above the cheapest vanilla ETFs on offer. The gloss is loud; the mechanics are the same old index sampling you could get for 0.03% elsewhere. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/bhyp; SEC EDGAR fund search for BHYP, https://www.sec.gov/edgar/search/#/q=BHYP)

The fund’s mandate, as filed, is to track a custom index of liquid US large-cap stocks, sampled rather than fully replicated. That means the issuer gets to choose which stocks sit in the basket, how often it rebalances, and how closely it hugs the index. The gap between the index and the fund’s holdings is the tracking error investors pay to avoid, while the issuer pockets the spread between the stated fee and the actual cost of running the sampler. The FINRA Fund Analyzer confirms the fee is explicit but does not expose the portfolio’s daily composition, turnover, or tracking difference, leaving investors to trust the wrapper more than the underlying mechanics. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

The SEC filings do not parse the fund’s AUM, turnover, or holdings at daily granularity, so the only public evidence of the basket’s composition is the issuer’s periodic disclosure, which arrives weeks after the fact. The Nasdaq page confirms the ticker trades, but the liquidity you see on screen is the liquidity the market chooses to offer, not a promise from the issuer. The “hyperliquid” label, therefore, is a marketing flourish bolted onto an index sampler, and the fund’s true liquidity is whatever the market decides to give it at 2 p.m. on a Friday. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/bhyp; SEC EDGAR fund search for BHYP, https://www.sec.gov/edgar/search/#/q=BHYP)

The chart route for BHYP on Nasdaq shows the ticker’s price action, but the renderer cannot infer levels or trends-only what the chart displays. Treat the chart as a price tape, not a crystal ball. The fund’s expense ratio sits at 0.45% per the FINRA Fund Analyzer, which is explicit; the fund’s holdings, turnover, and tracking difference are not parsed in the public rail, so the distance between the wrapper’s promise and the basket’s reality remains officially undisclosed. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/; Nasdaq, https://www.nasdaq.com/market-activity/etf/bhyp)

What changed today: the ticker traded on Nasdaq as usual; no new filings, holdings updates, or issuer statements were disclosed in the public rail. The fund’s liquidity and tracking behaviour are unchanged from the last disclosure cycle. The evidence does not include AUM, turnover, holdings composition, or tracking error figures, so any claim beyond what the filings and analyser confirm is inference, not fact. The next meaningful update would be the issuer’s next periodic filing, which could disclose holdings or turnover, or a prospectus supplement that tweaks the methodology or fee. Until then, BHYP trades on the promise of “hyperliquid” and the mechanical reality of an index sampler wrapped in a fee. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/bhyp; SEC EDGAR fund search for BHYP, https://www.sec.gov/edgar/search/#/q=BHYP; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)